January 2024

MIMS Full Prescribing Update

New / Revised

Product Name

Section changed
New Aciclovir Accord
New Aclasta (France)
New Ampicillin for Injection, USP (Eugia, USA)
New B-Patch
New Cipla Bisoprolol
New Comirnaty Omicron XBB.1.5
New Dabigatran Sandoz
New Estramon (Germany)
New Famotidine Tablets USP (BluePoint, USA)
New Fluoxetine Capsules (Medreich, UK)
New Fluoxetine Capsules (Morningside, UK)
New Gastrografin (Bayer, UK)
New Gliclazide MR Viatris
New Ixarola
New Misoprostol Tablets (ANI Pharmaceuticals)
New Morphini HCl Streuli Oral Drops (Switzerland)
New Mycophenolic Acid ARX
New Mycotex
New Paracetamol Kabi (Germany)
New Sabril (UK)
New Sugammadex Accord
New Sugammadex Sandoz
New Sugammadex Viatris
New Tamsulosin Lupin SR
New Vitarubin Depot (Streuli Pharma, Switzerland)
New Zoledronate-RDY 5
New Zypadhera (Germany)
Revised Act-HIB TGA Date
Revised Adacel Polio Qualitative and Quantitative Composition
Revised Adenosine Baxter Adverse Effects (Undesirable Effects)
Revised Adsine Adverse Effects (Undesirable Effects)
Revised Amitriptyline Viatris Overdose
Revised APO-Citalopram Special Warnings and Precautions for Use, Sponsor
Revised APO-Escitalopram Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised APO-Exemestane Sponsor
Revised APO-Ezetimibe Sponsor
Revised APO-Galantamine MR Sponsor
Revised APOHEALTH Thrush 3 and 6 Day Cream (was APO-Clotrimazole) Product Name change
Revised APO-Lansoprazole ODT Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised APO-Latanoprost Sponsor
Revised APO-Lisinopril Adverse Effects (Undesirable Effects),Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use, Sponsor
Revised APO-Metoprolol TGA Date
Revised APO-Pantoprazole TGA Date
Revised APO-Tamsulosin SR Sponsor
Revised APO-Telmisartan HCTZ Sponsor
Revised APO-Temozolomide Sponsor
Revised APX-Citalopram Special Warnings and Precautions for Use
Revised APX-Escitalopram Adverse Effects (Undesirable Effects)
Revised APX-Lamotrigine Pharmacological Properties, Special Warnings and Precautions for Use
Revised APX-Montelukast (was Montelukast APOTEX) Product Name change
Revised APX-Sotalol Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Aridon APN List of Excipients, Sponsor
Revised Arsenic Trioxide Juno Contraindications, Fertility, Pregnancy and Lactation
Revised ARX-Mycophenolate (was Mycophenolate APOTEX) Product Name change
Revised ARX-Sevelamer (was Sevelamer APOTEX) Product Name change
Revised Ausfam Adverse Effects (Undesirable Effects)
Revised Ausgem TGA Date
Revised Azacitidine Sandoz Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Azarga Nature and Contents of Container
Revised Azopt Nature and Contents of Container
Revised Benlysta Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Blooms the Chemist Escitalopram Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Blooms the Chemist Ezetimibe Sponsor
Revised Brilinta Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use
Revised BrinzoQuin Nature and Contents of Container
Revised Cholstat Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Citalopram Sandoz Special Warnings and Precautions for Use
Revised Clindamycin Viatris Nature and Contents of Container, Product Name change
Revised Cymbalta Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised DBL Oxaliplatin Concentrate Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Precautions for Storage
Revised Dexamethasone Medsurge Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use
Revised Diabex XR 1000 Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Diabex XR 500 Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Diaformin XR 1000 Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Diclofenac Sodium Viatris Product Name change
Revised Dilart List of Excipients, Special Precautions for Storage
Revised Dimethyl Fumarate Sandoz Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Dizole Qualitative and Quantitative Composition
Revised DuoTrav Nature and Contents of Container
Revised Durogesic Adverse Effects (Undesirable Effects)
Revised Eferas TGA Date
Revised EllaOne Sponsor, TGA Date
Revised Emend IV TGA Date
Revised Endep Overdose
Revised Erbitux Dose and Method of Administration, Overdose, Pharmaceutical Form, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Escitalopram Sandoz Adverse Effects (Undesirable Effects)
Revised Estrofem Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Extine Special Warnings and Precautions for Use
Revised Eylea Dose and Method of Administration, Pharmacological Properties
Revised Ezemichol Sponsor
Revised Ezetimibe/Simvastatin Sandoz Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions
Revised Faverin Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Femoston 1/10 Interactions with Other Medicines and Other Forms of Interactions
Revised Femoston 2/10 Interactions with Other Medicines and Other Forms of Interactions
Revised Femoston-Conti Interactions with Other Medicines and Other Forms of Interactions, List of Excipients
Revised Fentanyl GH Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Flarex Nature and Contents of Container
Revised Flolan Special Precautions for Storage
Revised Fluorouracil Ebewe Adverse Effects (Undesirable Effects)
Revised Fluoxetine Sandoz Special Warnings and Precautions for Use
Revised FluQuadri Qualitative and Quantitative Composition
Revised Fluzone High-Dose Quadrivalent Qualitative and Quantitative Composition
Revised Foradile TGA Date
Revised Galvus Adverse Effects (Undesirable Effects)
Revised GenRx Tamoxifen TGA Date
Revised Glyceryl Trinitrate Medsurge Product Name change, Sponsor
Revised Glypressin Solution Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Humatrope TGA Date
Revised Hydromorphone-hameln, Hydromorphone-hameln-HP Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Ilevro TGA Date
Revised Ipol TGA Date
Revised Isentress, Isentress HD TGA Date
Revised Jemperli Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Kapanol Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Keytruda Pharmacological Properties, Special Warnings and Precautions for Use
Revised Kineret Adverse Effects (Undesirable Effects)
Revised Lacosamide ARX Sponsor
Revised Levetiracetam IV ARX (was Levetiracetam IV APOTEX) Adverse Effects (Undesirable Effects), Product Name change, Special Precautions for Storage
Revised Levonorgestrel-1 GH Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Levothyroxine Lup Special Warnings and Precautions for Use
Revised Libtayo Adverse Effects (Undesirable Effects), Pharmacological Properties, Therapeutic Indications
Revised Logem Pharmacological Properties, Special Warnings and Precautions for Use
Revised Lonquex Special Precautions for Storage
Revised Lucrin Depot Paediatric Prefilled Dual Chamber Syringe (PDS) Injection 3 Month Adverse Effects (Undesirable Effects), Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use, Special Warnings and Precautions for Use
Revised Lucrin Depot Prefilled Dual Chamber Syringe (PDS) Injection Adverse Effects (Undesirable Effects), Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use, Special Warnings and Precautions for Use
Revised Lurasidone Sandoz Adverse Effects (Undesirable Effects)
Revised Lynparza Tablets Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Maviret Pharmacological Properties
Revised Mercaptopurine-Link Adverse Effects (Undesirable Effects)
Revised Metformin Mylan Product Name change
Revised Mevadol Forte Sponsor, TGA Date
Revised Mircera Dose and Method of Administration
Revised Motilium TGA Date
Revised Myoview TGA Date
Revised Myozyme Adverse Effects (Undesirable Effects)
Revised Neurontin Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised NNA-Ezetimibe/Simvastatin Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use, Sponsor
Revised Nuvaxovid Adverse Effects (Undesirable Effects), Dose and Method of Administration, List of Excipients, Pharmacological Properties, Therapeutic Indications
Revised Oxycodone-hameln Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Special Warnings and Precautions for Use
Revised Ozempic Adverse Effects (Undesirable Effects)
Revised Ozmep Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Paroxetine GH Special Warnings and Precautions for Use
Revised Paroxetine Sandoz Special Warnings and Precautions for Use
Revised Paxtine Nature and Contents of Container, Pharmaceutical Form, Special Warnings and Precautions for Use
Revised Pfizer (Australia) Sodium Chloride 0.9% Intravenous Infusion Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition
Revised Pharmacor Fingolimod TGA Date
Revised Phebra Calcium Chloride Dihydrate 10% Injection Special Warnings and Precautions for Use
Revised Pirfenidone Sandoz Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Plaquenil Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties
Revised Pramin Qualitative and Quantitative Composition
Revised Pravastatin Sandoz Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Precedex Pharmacological Properties, Special Warnings and Precautions for Use
Revised Precedex Ready to Use Pharmacological Properties, Special Warnings and Precautions for Use
Revised Pro-Banthine Sponsor
Revised ProCalm Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use
Revised Reagila Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Relpax Migraine Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form
Revised Remifentanil Viatris Dose and Method of Administration, Effects on Ability to Drive and Use Machines
Revised Riximyo Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation
Revised Sandostatin Pharmacological Properties
Revised Seasonique Dose and Method of Administration, Nature and Contents of Container
Revised Septrin Forte Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Septrin Sugar Free Oral Liquid Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use
Revised Sical Nature and Contents of Container, Special Precautions for Storage
Revised Simbrinza TGA Date
Revised Simvastatin Sandoz Interactions with Other Medicines and Other Forms of Interactions
Revised Sinemet Adverse Effects (Undesirable Effects)
Revised Sinemet CR 200/50 Adverse Effects (Undesirable Effects)
Revised Sleep Safe Balance TGA Date
Revised Solavert Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Soolantra TGA Date
Revised Sotacor Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Spinraza Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Stamaril TGA Date
Revised Steglatro Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Steglujan Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Stelara Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Sublocade Shelf Life, Special Precautions for Storage
Revised Sumatran Sponsor
Revised Talam Special Warnings and Precautions for Use, Sponsor
Revised Talam 20 mg Special Warnings and Precautions for Use
Revised Teltartan HCT TGA Date
Revised Tenofovir GH TGA Date
Revised Tobrex Nature and Contents of Container
Revised Tramadol Sandoz Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Tremfya Adverse Effects (Undesirable Effects), Pharmacological Properties
Revised Vagifem Low Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Vaxigrip Tetra Qualitative and Quantitative Composition
Revised Vfend Interactions with Other Medicines and Other Forms of Interactions
Revised Xeomin Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New indication, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Yescarta Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Zactin Special Warnings and Precautions for Use
Revised Zactin Tabs Special Warnings and Precautions for Use
Revised Zavicefta Adverse Effects (Undesirable Effects)
Revised Zinopril TGA Date
Revised ZolaCos CP Dose and Method of Administration, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Zoladex 10.8 mg Implant TGA Date
Revised Zoladex 3.6 mg Implant TGA Date
Revised Zolinza TGA Date
Revised Zumenon Interactions with Other Medicines and Other Forms of Interactions
Revised Zyprexa TGA Date
Revised Zyprexa IM TGA Date
Deleted Blooms the Chemist Prochlorperazine
Deleted Ikorel
Deleted Panadol Cold & Flu Night Relief PE
Deleted Segluromet

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au